The Alaris system is an infusion pump and vital signs-monitoring system. The pumps deliver controlled amounts of fluids, medications, blood and blood products to patients.
Becton Dickinson, based in Franklin Lakes, N.J., said it found multiple system errors, software errors and use-related errors that can lead to infusion delays and interruptions of infusion and slower or faster than expected delivery of medication.
The FDA classified the recall as Class I, the most serious type, meaning use of the recalled products can cause serious injury or death.
Read the full news release here.
More articles on supply chain:
Amazon, Walmart fighting price-gouging on coronavirus supplies
Rural hospitals taking drastic steps to get supplies amid coronavirus outbreak
Thermo Fisher to acquire Qiagen in $11.5B deal
